Form 8-K - Current report:
SEC Accession No. 0001104659-25-048948
Filing Date
2025-05-15
Accepted
2025-05-15 07:14:53
Documents
15
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2514981d1_8k.htm   iXBRL 8-K 30109
2 EXHIBIT 99.1 tm2514981d1_ex99-1.htm EX-99.1 44332
3 GRAPHIC tm2514981d1_ex99-1img001.jpg GRAPHIC 16641
  Complete submission text file 0001104659-25-048948.txt   282263

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zbio-20250515.xsd EX-101.SCH 3014
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zbio-20250515_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zbio-20250515_pre.xml EX-101.PRE 22358
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2514981d1_8k_htm.xml XML 3794
Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Filer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42270 | Film No.: 25948677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)